Mousavi, Seyed Reza, Ayoubi, Zeinab, Vahabzadeh, Maryam, Jarahi, Lida, Abdi Valami, Khadijeh, Rahimi, Hamid Reza. (1402). Triiodothyronine Mitigates Cardiac Dysfunction in Aluminum Phosphide Poisoning: Findings from a Randomized Clinical Trial. , 12(2), 54-59. doi: 10.22038/apjmt.2023.22797
Seyed Reza Mousavi; Zeinab Ayoubi; Maryam Vahabzadeh; Lida Jarahi; Khadijeh Abdi Valami; Hamid Reza Rahimi. "Triiodothyronine Mitigates Cardiac Dysfunction in Aluminum Phosphide Poisoning: Findings from a Randomized Clinical Trial". , 12, 2, 1402, 54-59. doi: 10.22038/apjmt.2023.22797
Mousavi, Seyed Reza, Ayoubi, Zeinab, Vahabzadeh, Maryam, Jarahi, Lida, Abdi Valami, Khadijeh, Rahimi, Hamid Reza. (1402). 'Triiodothyronine Mitigates Cardiac Dysfunction in Aluminum Phosphide Poisoning: Findings from a Randomized Clinical Trial', , 12(2), pp. 54-59. doi: 10.22038/apjmt.2023.22797
Mousavi, Seyed Reza, Ayoubi, Zeinab, Vahabzadeh, Maryam, Jarahi, Lida, Abdi Valami, Khadijeh, Rahimi, Hamid Reza. Triiodothyronine Mitigates Cardiac Dysfunction in Aluminum Phosphide Poisoning: Findings from a Randomized Clinical Trial. , 1402; 12(2): 54-59. doi: 10.22038/apjmt.2023.22797

Triiodothyronine Mitigates Cardiac Dysfunction in Aluminum Phosphide Poisoning: Findings from a Randomized Clinical Trial

Asia Pacific Journal of Medical Toxicology
دوره 12، شماره 2، پاییز 2023، صفحه 54-59    اصل مقاله (838.46 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22038/apjmt.2023.22797
نویسندگان
Seyed Reza Mousavi1؛ Zeinab Ayoubi1؛ Maryam Vahabzadeh1؛ Lida Jarahi* 2؛ Khadijeh Abdi Valami1؛ Hamid Reza Rahimi3
1Department of Forensic Medicine and Clinical Toxicology, Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
2Department of Community Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3Department of Medical Genetics and Molecular Medicine, Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
چکیده
Introduction: Aluminum phosphide (AlP) poisoning, commonly known as rice tablet poisoning, is a lethal method of suicide with no known antidotes. Thyroid hormones have inotropic effects that can potentially reverse hemodynamic instability and improve cardiac output. This study investigated the effects of Triiodothyronine (T3) on the cardiac function of patients with aluminum phosphide poisoning.
Methods: In this randomized clinical trial, 24 patients with confirmed ALP poisoning were recruited. The intervention group received T3 treatment in addition to standard treatment, while the control group received only standard treatment. Demographic variables, cardiac parameters, biochemical markers, and oxidative stress tests were evaluated.
Results: The majority of participants were men (60%) in their thirties (intervention: 32±17.4 years; control: 30±11.6 years). Following treatment, both systolic and diastolic blood pressures had significantly higher mean differences in the T3 group compared to the control group (18.7±9.3, P=0.05 and 14.1±5.9, P=0.03 respectively). While both groups showed improvement in mean arterial pH, the intervention group exhibited a significantly greater improvement 12 hours after the administration of T3, which was significantly different from both the baseline and control groups (p=0.04, 0.009 respectively). Additionally, the intervention group had a lower QRS and QTc interval compared to admission time.
Conclusion: Triiodothyronine administration has been shown to maintain a higher range of SBP, control cardiogenic shock, regulate metabolism, improve acidosis and blood pressure, and ultimately enhance recovery in patients with aluminum phosphide poisoning. Furthermore, it may have cardio-protective effects on these patients.
 
 
کلیدواژه‌ها
Aluminum Phosphide؛ Phosphine؛ Poisoning؛ Triiodothyronine
مراجع
آمار
تعداد مشاهده مقاله: 404
تعداد دریافت فایل اصل مقاله: 607
دانشگاه علوم پزشکی مشهد
آمار
تعداد نشریات29
تعداد شماره‌ها2,320
تعداد مقالات24,811
تعداد مشاهده مقاله82,287,519
تعداد دریافت فایل اصل مقاله45,500,492